Publicacions (86) Publicacions de Jesús Pérez Losada

filter_list

2026

  1. AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors

    Cancer Letters, Vol. 647

2025

  1. El papel de GAB1 en el cáncer de mama

    XI Jornadas de Investigadoras de Castilla y León: la aventura de la ciencia y tecnología (Servicio de Publicaciones e Imagen Institucional), pp. 203

  2. Emerging multifaceted roles of the microbiome in cancer susceptibility

    WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 16, Núm. 9

  3. Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model

    Biomolecules, Vol. 15, Núm. 5

  4. Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies

    International Journal of Molecular Sciences, Vol. 26, Núm. 7

2024

  1. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice

    eBioMedicine, Vol. 106

  2. Immunosuppression is associated with an increased risk of distant metastases in high-risk cutaneous squamous cell carcinoma: A retrospective cohort study

    JAAD International, Vol. 15, pp. 74-77

  3. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

    Clinical and Translational Medicine, Vol. 14, Núm. 2

2023

  1. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma

    Clinical and Experimental Dermatology

  2. Cutaneous squamous cell carcinoma: From biology to therapy

    Advances in Surgical and Medical Specialties (Taylor and Francis), pp. 393-424

  3. Identification of Genomic Regions Implicated in Susceptibility to Schistosoma mansoni Infection in a Murine Backcross Genetic Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  4. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  5. Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

    Frontiers in Oncology, Vol. 13

  6. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

  7. The Role of GAB1 in Cancer

    Cancers, Vol. 15, Núm. 16

2022

  1. Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity

    International Journal of Molecular Sciences, Vol. 23, Núm. 14

  2. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  3. From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer

    Frontiers in Oncology, Vol. 11

  4. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

  5. iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers

    WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 13, Núm. 7, pp. 616-629